No. 24A1215
MSN Pharmaceuticals, Inc., et al v. Novartis Pharmaceuticals Corporation
Tags: after-arising-technology enablement-doctrine federal-circuit genus-claim patent-law patent-validity
Key Terms:
Patent
Patent
Latest Conference:
N/A
Question Presented (AI Summary)
Whether a patent may validly claim a genus without describing or enabling species of the genus that utilize after-arising technology
Question Presented (from Petition)
No question identified. :
Docket Entries
2025-06-11
Application (24A1215) granted by The Chief Justice extending the time to file until August 22, 2025.
2025-06-06
Application (24A1215) to extend the time to file a petition for a writ of certiorari from June 23, 2025 to August 22, 2025, submitted to The Chief Justice.
Attorneys
MSN Pharmaceuticals, Inc., et al.
Amit Ramnik Vora — Kasowitz Benson Torres LLP, Petitioner
Amit Ramnik Vora — Kasowitz Benson Torres LLP, Petitioner